Market News

State Farm Mutual Automobile Insurance Company Has Lifted By $87.84 Million Its Texas Instrs (TXN) Position; Altiris (ATRS) Sentiment Is 1.29

Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company has market cap of $341.55 million. The companyÂ’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis and psoriasis patients to self-inject methotrexate at home; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache; ZOMA-Jet and Twin-Jector, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle; and VIBEX disposable pressure-assisted auto injectors. It currently has negative earnings. In addition, the firm is developing VIBEX auto injectors for treating anaphylaxis; disposable pen injectors for diabetes and osteoporosis; Makena QuickShot auto injectors for reducing risk of preterm birth; and VIBEX QS Testosterone for testosterone replacement therapy for men who have testosterone deficiency.

State Farm Mutual Automobile Insurance Company increased Texas Instrs Inc (TXN) stake by 86.52% reported in 2017Q3 SEC filing. State Farm Mutual Automobile Insurance Company acquired 986,941 shares as Texas Instrs Inc (TXN)’s stock rose 5.05%. The State Farm Mutual Automobile Insurance Company holds 2.13M shares with $190.73 million value, up from 1.14 million last quarter. Texas Instrs Inc now has $115.16 billion valuation. The stock decreased 1.94% or $2.31 during the last trading session, reaching $116.85. About 4.37 million shares traded. Texas Instruments Incorporated (NASDAQ:TXN) has risen 40.31% since January 18, 2017 and is uptrending. It has outperformed by 23.61% the S&P500.

Since July 31, 2017, it had 0 insider purchases, and 13 insider sales for $125.79 million activity. 16,990 shares were sold by BLINN MARK A, worth $1.64 million. $43.43 million worth of Texas Instruments Incorporated (NASDAQ:TXN) was sold by TEMPLETON RICHARD K on Thursday, October 26. Whitaker Darla H sold $11.43M worth of Texas Instruments Incorporated (NASDAQ:TXN) on Thursday, October 26. Shares for $2.14 million were sold by BABB RALPH W JR. Shares for $25.40 million were sold by CRUTCHER BRIAN T. 124,536 shares were sold by ANDERSON STEPHEN A., worth $11.97 million on Friday, October 27. $2.14 million worth of Texas Instruments Incorporated (NASDAQ:TXN) was sold by SANDERS WAYNE R.

Among 37 analysts covering Texas Instruments (NASDAQ:TXN), 17 have Buy rating, 2 Sell and 18 Hold. Therefore 46% are positive. Texas Instruments had 94 analyst reports since July 24, 2015 according to SRatingsIntel. As per Tuesday, April 19, the company rating was downgraded by Raymond James. Mizuho maintained Texas Instruments Incorporated (NASDAQ:TXN) rating on Thursday, October 27. Mizuho has “Neutral” rating and $68 target. Citigroup maintained the stock with “Buy” rating in Monday, September 25 report. The firm has “Outperform” rating by Oppenheimer given on Tuesday, December 15. The rating was downgraded by Goldman Sachs on Wednesday, February 3 to “Sell”. The stock of Texas Instruments Incorporated (NASDAQ:TXN) earned “Outperform” rating by RBC Capital Markets on Friday, October 2. Cowen & Co maintained the stock with “Market Perform” rating in Thursday, April 28 report. The rating was maintained by Bank of America on Wednesday, October 25 with “Buy”. The rating was maintained by BMO Capital Markets on Thursday, August 31 with “Buy”. The rating was maintained by Raymond James with “Market Perform” on Friday, June 16.

Investors sentiment increased to 1.12 in Q3 2017. Its up 0.02, from 1.1 in 2017Q2. It increased, as 55 investors sold TXN shares while 333 reduced holdings. 104 funds opened positions while 332 raised stakes. 802.74 million shares or 3.16% more from 778.17 million shares in 2017Q2 were reported. Cambridge Financial Gp Inc holds 76,467 shares. Teachers Ins Annuity Association Of America stated it has 117,782 shares. Private Wealth Ptnrs Lc accumulated 0.04% or 2,242 shares. Greenleaf Tru reported 0.01% in Texas Instruments Incorporated (NASDAQ:TXN). First Allied Advisory Svcs invested in 0.04% or 11,425 shares. Ims Management stated it has 0.19% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN). Whittier Company invested 0.1% in Texas Instruments Incorporated (NASDAQ:TXN). Argyle Cap Management reported 0.19% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN). Tower Research Capital Ltd (Trc) stated it has 11,046 shares. Breton Hill Capital Ltd invested in 14,928 shares. Sg Americas Securities Limited Liability Corp invested in 0.04% or 46,047 shares. Hamilton Point Ltd Company reported 38,010 shares. Hbk Sorce Advisory Ltd Liability Corporation invested in 2,454 shares or 0.03% of the stock. Bragg Financial Advsr invested in 82,417 shares or 1.13% of the stock. Buckingham Cap Inc reported 6,285 shares stake.

The stock decreased 2.24% or $0.05 during the last trading session, reaching $2.18. About 347,260 shares traded. Antares Pharma, Inc. (ATRS) has risen 207.14% since January 18, 2017 and is uptrending. It has outperformed by 190.44% the S&P500.

Jw Asset Management Llc holds 3.97% of its portfolio in Antares Pharma, Inc. for 1.67 million shares. Armistice Capital Llc owns 4.20 million shares or 1.6% of their US portfolio. Moreover, Broadfin Capital Llc has 1.54% invested in the company for 3.21 million shares. The Minnesota-based Perkins Capital Management Inc has invested 1.24% in the stock. Thompson Davis & Co. Inc., a Virginia-based fund reported 112,768 shares.

Analysts await Antares Pharma, Inc. (NASDAQ:ATRS) to report earnings on March, 13. They expect $-0.03 EPS, 0.00% or $0.00 from last year’s $-0.03 per share. After $-0.03 actual EPS reported by Antares Pharma, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since January 1, 0001, it had 0 buys, and 2 insider sales for $1.04 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *